Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
复制标题
DOI:
10.1016/j.exppara.2011.02.016
复制
发表时间:
2011-06
影响因子:
2.1
通讯作者:
Curiel, Tyler J.
中科院分区:
文献类型:
--
作者:
Brumlik, Michael J.;Nkhoma, Standwell;Kious, Mark J.;Thompson, George R., III;Patterson, Thomas F.;Siekierka, John J.;Anderson, Tim J. C.;Curiel, Tyler J.
关键词:
We recently demonstrated that human p38 mitogen-activated protein kinase (MAPK) inhibitors reduced in vitro and in vivo replication of the protozoan parasites Toxoplasma gondii and Encephalitozoon cuniculi. In this study, we assessed the efficacy of five p38 MAPK inhibitors to block the replication of Plasmodium falciparum in human erythrocytes cultured ex vivo and demonstrate that the pyridinylimidazole RWJ67657 and the pyrrolobenzimidazole RWJ68198 reduced Plasmodium falciparum replication, yielded trophozoites that were greatly diminished in size at 24 h, and that these two agents interfered with stage differentiation. Interestingly, the chloroquine-resistant strain W2 was significantly more sensitive to these drugs than was the chloroquine-sensitive strain HB3. These results suggest that pyridinylimidazoles and pyrrolobenzimidazoles designed to inhibit human p38 MAPK activation can be developed to treat malaria.
登录
查看更多内容
影响因子:
64.8
作者:
Gamo, Francisco-Javier;Sanz, Laura M.;Garcia-Bustos, Jose F.
通讯作者:
Garcia-Bustos, Jose F.
DOI:
10.1073/pnas.95.13.7422
发表时间:
1998-06-23
影响因子:
11.1
作者:
Shapiro, L;Heidenreich, KA;Dinarello, CA
通讯作者:
Dinarello, CA
影响因子:
27.4
作者:
Hammaker D;Firestein GS
通讯作者:
Firestein GS
DOI:
10.1155/2011/971968
发表时间:
2011
期刊:
Journal of signal transduction
影响因子:
--
作者:
Brumlik MJ;Pandeswara S;Ludwig SM;Murthy K;Curiel TJ
通讯作者:
Curiel TJ
影响因子:
2.7
作者:
Biftu, T;Feng, D;Wyvratt, M
通讯作者:
Wyvratt, M